; the acquisition, distribution, or stockpiling of protective equipment and medical supplies; and the development of vaccines and treatments; (5) the economic impact of the coronavirus crisis on individuals, communities, small businesses, health care providers, States, and local government entities; (6) any disparate impacts of the coronavirus crisis on different communities and populations, including with respect to race, ethnicity, age, sex, gender identity, sexual orientation, disability, and geographic region, and any measures taken to address such disparate impacts; (7) executive branch policies, deliberations, decisions, activities, and internal and external communications related to the coronavirus crisis; (8) the protection of whistleblowers who provide information about waste, fraud, abuse, or other improper activities related to the coronavirus crisis; (9) cooperation by the executive branch and others with Congress, the Inspectors General, the Government Accountability Office, and others in connection with oversight of the preparedness for and response to the coronavirus crisis